Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.

Vaccine

Department of Population Health and Disease Prevention, University of California, 653 E. Peltason Drive, Irvine, CA 92697, United States. Electronic address:

Published: August 2018

Subacute sclerosing panencephalitis (SSPE) is a neurodegenerative disease caused by measles virus. We estimate SSPE age-specific mortality in the United States, 1979-2016. The general decline in SSPE mortality reflects that of measles. Shifts, over time, in SSPE mortality by age echo changes in the age distribution of measles in the 1970s and in the 1989-91 outbreak. The current epidemiological situation is that autochthonous SSPE will disappear in the United States, assuming measles vaccination rates remain high.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2018.07.030DOI Listing

Publication Analysis

Top Keywords

united states
12
subacute sclerosing
8
sclerosing panencephalitis
8
mortality united
8
states 1979-2016
8
sspe mortality
8
sspe
6
mortality
4
panencephalitis mortality
4
1979-2016 vaccine-induced
4

Similar Publications

Correspondence regarding "Letter to the editor: TMS-evoked potentials provide novel neurophysiological features of Tourette syndrome".

Parkinsonism Relat Disord

January 2025

Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, Ohio, United States. Electronic address:

View Article and Find Full Text PDF

Multidimensional sleep health and cognitive function across adulthood.

Sleep Health

January 2025

Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, USA; Memory Clinic, Department of Neurology, Charles University, Second Faculty of Medicine and Motol Hospital, Prague, Czech Republic.

Study Objectives: Sleep is essential for proper function of the mind and body. Studies report the effect of sleep problems on cognition but focus on only a single or limited number of sleep indicators or on clinical populations (e.g.

View Article and Find Full Text PDF

Lupus nephritis: Biomarkers.

Adv Clin Chem

January 2025

University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, ON, Canada. Electronic address:

Lupus nephritis (LN) or renal involvement of systemic lupus erythematosus (SLE), is a common manifestation occurring in at least 50 % of SLE patients. LN remains a significant source of morbidity, often leading to progressive renal dysfunction and is a major cause of death in SLE. Despite these challenges, advances in the understanding of the pathogenesis and genetic underpinnings of LN have led to a commendable expansion in available treatments over the past decade.

View Article and Find Full Text PDF

Ion mobility spectrometry and ion mobility-mass spectrometry in clinical chemistry.

Adv Clin Chem

January 2025

Department of Chemistry, Center for Innovative Technology, Institute of Chemical Biology, Institute for Integrative Biosystems Research and Education, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, United States. Electronic address:

Advancements in clinical chemistry have major implications in terms of public health, prompting many clinicians to seek out chemical information to aid in diagnoses and treatments. While mass spectrometry (MS) and hyphenated-MS techniques such as LC-MS or tandem MS/MS have long been the analytical methods of choice for many clinical applications, these methods routinely demonstrate difficulty in differentiating between isomeric forms in complex matrices. Consequently, ion mobility spectrometry (IM), which differentiates molecules on the basis of size, shape, and charge, has demonstrated unique advantages in the broad application of stand-alone IM and hyphenated IM instruments towards clinical challenges.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!